Oral contraceptive regimen
AssigneeOrtho Pharmaceutical Corporation
InventorSamuel A. Pasquale
Life of this patent
Estimating the term…
Abstract
An oral contraceptive regimen in which a progestin is administered from the fifth through the twenty-fifth day of the physiological cycle is described. The amount of progestin administered is serially increased during the period of administration; regular menses occurs when administration of the regimen is complete.
Claims6
In a method for the prevention of conception of the type wherein a progestin is administered to the human female serially over at least the fifth through the twenty-fifth day of the cycle, the improvement consisting of:
- administering a substantially higher dose of a progestin during approximately the last 7 days of administration than during approximately the first 7 days of administration and terminating the administration of the progestational agent on or after the twenty-fifth day of the cycle.
In a method for the prevention of conception of the type wherein a progestin is administered to the human female serially over at least the fifth through the twenty-fifth day of the cycle, the improvement consisting of:
- serially increasing the dose of progestin substantially over the course of administration to thus produce an increasing gradient in the circulating progestin level and then terminating the administration of the progestational agent on or after the twenty-fifth day of the cycle.
Dependencies are inferred from the claim text.